RxDoctor Payments Data

Romulus Ramos, NP

Nurse Practitioner · Valencia, CANPI 1821456716

Payments from drug & device makers

$804in general payments, 2019–2025

Across 36 payments — averaging $22.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$193
  • Azurity Pharmaceuticals, Inc.$112
  • Boston Scientific$83
  • Almatica Pharma LLC$70
  • Globus Medical$67
  • Si-bone, Inc.$43
  • plus $236 from 11 others

What the payments were for

  • Food & beverage$804100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$804 in reported general payments places this provider in the 75th percentile of 6,779 nurse practitioner providers in California.

See all nurse practitioner providers in California

Medicare billing

Part B allowed, 2024
$112,582
Medicare patients
566
Services billed
1,756

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
GraliseGabapentin15$19,593
SavellaMilnacipran Hcl12$5,788
Diclofenac Sodium11$2,859
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen76$1,656
Pregabalin46$1,492
Gabapentin88$1,117
Celecoxib22$461
Methylprednisolone20$133
Methocarbamol12$111
Etodolac11$108
Meloxicam19$105
Tramadol Hcl15$71
Cyclobenzaprine Hcl19$65

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Almatica Pharma LLCGralise$70$19,59315 claims
AbbVieSavella$193$5,78812 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 6,779 nurse practitioner providers in California.

Other nurse practitioner in Valencia

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →